These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


928 related items for PubMed ID: 19389329

  • 1. Aripiprazole in children and adolescents with bipolar disorder comorbid with attention-deficit/hyperactivity disorder: a pilot randomized clinical trial.
    Tramontina S, Zeni CP, Ketzer CR, Pheula GF, Narvaez J, Rohde LA.
    J Clin Psychiatry; 2009 Apr 21; 70(5):756-64. PubMed ID: 19389329
    [Abstract] [Full Text] [Related]

  • 2. Acute treatment of pediatric bipolar I disorder, manic or mixed episode, with aripiprazole: a randomized, double-blind, placebo-controlled study.
    Findling RL, Nyilas M, Forbes RA, McQuade RD, Jin N, Iwamoto T, Ivanova S, Carson WH, Chang K.
    J Clin Psychiatry; 2009 Oct 21; 70(10):1441-51. PubMed ID: 19906348
    [Abstract] [Full Text] [Related]

  • 3. Young mania rating scale line item analysis in pediatric subjects with bipolar I disorder treated with aripiprazole in a short-term, double-blind, randomized study.
    Mankoski R, Zhao J, Carson WH, Mathew SJ, Forbes RA.
    J Child Adolesc Psychopharmacol; 2011 Aug 21; 21(4):359-64. PubMed ID: 21823911
    [Abstract] [Full Text] [Related]

  • 4. Aripiprazole in juvenile bipolar disorder comorbid with attention-deficit/hyperactivity disorder: an open clinical trial.
    Tramontina S, Zeni CP, Pheula GF, de Souza CK, Rohde LA.
    CNS Spectr; 2007 Oct 21; 12(10):758-62. PubMed ID: 17934380
    [Abstract] [Full Text] [Related]

  • 5. Methylphenidate combined with aripiprazole in children and adolescents with bipolar disorder and attention-deficit/hyperactivity disorder: a randomized crossover trial.
    Zeni CP, Tramontina S, Ketzer CR, Pheula GF, Rohde LA.
    J Child Adolesc Psychopharmacol; 2009 Oct 21; 19(5):553-61. PubMed ID: 19877980
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Aripiprazole for the treatment of pediatric bipolar I disorder: a 30-week, randomized, placebo-controlled study.
    Findling RL, Correll CU, Nyilas M, Forbes RA, McQuade RD, Jin N, Ivanova S, Mankoski R, Carson WH, Carlson GA.
    Bipolar Disord; 2013 Mar 21; 15(2):138-49. PubMed ID: 23437959
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit/hyperactivity disorder.
    Klassen AF, Miller A, Fine S.
    Pediatrics; 2004 Nov 21; 114(5):e541-7. PubMed ID: 15520087
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Aripiprazole monotherapy in nonpsychotic bipolar I depression: results of 2 randomized, placebo-controlled studies.
    Thase ME, Jonas A, Khan A, Bowden CL, Wu X, McQuade RD, Carson WH, Marcus RN, Owen R.
    J Clin Psychopharmacol; 2008 Feb 21; 28(1):13-20. PubMed ID: 18204335
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Aripiprazole monotherapy for maintenance therapy in bipolar I disorder: a 100-week, double-blind study versus placebo.
    Keck PE, Calabrese JR, McIntyre RS, McQuade RD, Carson WH, Eudicone JM, Carlson BX, Marcus RN, Sanchez R, Aripiprazole Study Group.
    J Clin Psychiatry; 2007 Oct 21; 68(10):1480-91. PubMed ID: 17960961
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Randomized, placebo-controlled trial of mixed amphetamine salts for symptoms of comorbid ADHD in pediatric bipolar disorder after mood stabilization with divalproex sodium.
    Scheffer RE, Kowatch RA, Carmody T, Rush AJ.
    Am J Psychiatry; 2005 Jan 21; 162(1):58-64. PubMed ID: 15625202
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 47.